Recent Finacing
Recent Raise
Allakos is a clinical-stage biopharmaceutical company developing antibody therapeutics targeting immunomodulatory receptors—notably Siglec-8—on mast cells and eosinophils, advancing AK002 through clinical and preclinical programs for allergic and inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors